In addition, comprehensive genomic profiling, which enables the identification of tumor-related alterations, has demonstrated that younger breast cancer patients have distinct somatic genomic profiles, methylation patterns and gene expression signatures associated with the dysregulation of genes including ESR1, GATA3 and FGFR1 (24, 27–29). This evidence concerns the gene ESR1 and neoplasm.